Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00440 | Maleimide-NH-PEG10-CH2CH2COONHS Ester | 1137109-22-8 |
| Maleimide-NH-PEG10-CH2CH2COONHS Ester is a versatile bioactive ester that can be used to develop targeted drug delivery systems. It acts as a linker to bind drugs or imaging agents to targeting molecules, facilitating their selective delivery to specific cells or tissues. In addition, it can be used in the development and synthesis of cancer treatment drugs. | Inquiry | |
| BADC-00441 | Mal-PEG8-NHS | 756525-93-6 |
| Mal-PEG8-NHS is a biochemical product widely used in drug delivery and in-depth biopharmaceutical research. As a polyethylene glycol (PEG) derivative conjugated to a maleimide moiety, it is widely used in drug delivery systems and bioconjugation. | Inquiry | |
| BADC-00442 | Mal-PEG6-NHS | 1137109-21-7 |
| Mal-PEG6-NHS is a widely employed biomedical reagent within drug delivery systems and bioconjugation processes. Embedding a maleimide moiety facilitates precise targeting, while supplemented with a polyethylene glycol (PEG) spacer, it accomplishes elevated solubility and biocompatibility. Resultantly, Mal-PEG6-NHS serves as a pivotal constituent enabling the formulation of therapeutic agents to combat a spectrum of illnesses encompassing cancer, cardiovascular ailments, and inflammatory disorders. | Inquiry | |
| BADC-00443 | Mal-PEG5-NHS | 1315355-92-0 |
| Mal-PEG5-NHS is a biomedical product that assumes a pivotal role in drug conjugation and protein modification. Its exceptional reactivity as a linker fosters targeted drug delivery, thereby ramping up therapeutic efficacy to unprecedented levels. | Inquiry | |
| BADC-00444 | Maleimide-NH-PEG4-CH2CH2COOPFP Ester | 1347750-84-8 |
| Maleimide-NH-PEG4-CH2CH2COOPFP Ester is a versatile compound used in the biomedical industry for the preparation of bioconjugates. It serves as a reactive linker, enabling the conjugation of drugs or biomolecules to specific targets. Particularly, it is commonly utilized in targeted drug delivery systems for the treatment of various diseases, such as cancer and autoimmune disorders. | Inquiry | |
| BADC-00445 | Maleimide-NH-PEG3-CH2CH2COOPFP Ester | 2101206-13-5 |
| Maleimide-NH-PEG3-CH2CH2COOPFP Ester is a basic compound widely used in the biomedical field. It is an indispensable linker for coordinating the conjugation of different biomolecules, thereby accelerating the precise administration of therapeutics and diagnostics. Its widespread use in the synthesis of pioneering drug therapies and bioconjugates has led to promising clinical benefits. | Inquiry | |
| BADC-00447 | Mal-amido-PEG2-NHS | 955094-26-5 |
| Mal-amido-PEG2-NHS is a non-cleavable ADC linker containing the Maleimide group, 2-unit PEG, and NHS ester. | Inquiry | |
| BADC-00448 | Mal-PEG-NHS | 1260092-50-9 |
| Mal-PEG-NHS is a bioconjugation reagent widely used in the biomedical industry. It is a maleimide-functionalized polyethylene glycol derivative with an NHS ester group at the other end. This compound is commonly utilized for the selective modification of proteins, peptides, and other biomolecules. It enables the conjugation of amine-containing drugs or targeting ligands to various disease-specific proteins or surfaces, thus facilitating targeted drug delivery and diagnostics. | Inquiry | |
| BADC-00449 | Mal-PEG4-PFP | 1415800-42-8 |
| Mal-PEG4-PFP ester is a PEG linker containing maleimide and PFP moieties. Maleimide is thiol-reactive and reacts between pH 6.5 and 7.5 to form thiol ester bonds. PFP moiety is amine-reactive and is less susceptible to undergoing hydrolysis. The hydrophilic PEG linker increases the water solubility of a compound in aqueous media. | Inquiry | |
| BADC-00450 | Mal-PEG4-NHS | 1325208-25-0 |
| Mal-PEG4-NHS is a non-cleavable ADC linker containing the Maleimide group, 4-unit PEG, and NHS ester. | Inquiry | |
| BADC-00451 | 2,5-dioxopyrrolidin-1-yl 2-(2-(2-(2-(2,5-dioxo-2H-pyrrol-1(5H)-yl)ethoxy)ethoxy)ethoxy)acetate | |
| 2,5-dioxopyrrolidin-1-yl 2-(2-(2-(2-(2,5-dioxo-2H-pyrrol-1(5H)-yl)ethoxy)ethoxy)ethoxy)acetate is a biomedical compound. Characterized by its complex molecular composition, it can be used as a candidate active ingredient for therapeutic intervention in a variety of diseases. Furthermore, it has potential use in the field of cancer treatment, as it disrupts the metabolic processes of malignant cells. | Inquiry | |
| BADC-00452 | Mal-PEG2-PFP | 1807512-47-5 |
| Mal-PEG2-PFP is a PEG linker containing maleimide and PFP moieties. Maleimide is thiol-reactive and reacts between pH 6.5 and 7.5 to form thiol ester bonds. PFP moiety is amine-reactive and is less susceptible to undergoing hydrolysis. The hydrophilic PEG linker increases the water solubility of a compound in aqueous media. | Inquiry | |
| BADC-00455 | 1-((1r,4r)-4-((2,5-dioxo-2H-pyrrol-1(5H)-yl)methyl)cyclohexanecarbonyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid | 1286837-77-1 |
| 1-((1R,4R)-4-((2,5-dioxo-2H-pyrrol-1(5H)-yl)methyl)cyclohexanecarbonyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid is an immensely potent pharmaceutical agent. Conspicuously, it demonstrates efficacy in combating diverse afflictions such as cancer and autoimmune disorders. Capitalizing on its distinct molecular configuration, it exhibits targeted activity on specific biological pathways, thereby ushering in novel prospects for efficacious therapeutic interventions. | Inquiry | |
| BADC-00461 | 4-succinimidyl-oxycarbonyl-α-(2-pyridyldithio)toluene | 160854-54-6 |
| Inquiry | ||
| BADC-00462 | SMPT | 112241-19-7 |
| Inquiry | ||
| BADC-00496 | succimimidyl-4-azidobutyrate | 943858-70-6 |
| Succimimidyl-4-azidobutyrate is a superior biopharmaceutical formulation that can facilitate breakthrough drug development and research efforts. As a chemically mediated linker, it accelerates the synthesis of targeted drugs, ultimately resulting in good precision in drug delivery and modulated drug release. | Inquiry | |
| BADC-00499 | Mal-PEG6-NHS ester | 1599472-25-9 |
| Mal-PEG6-NHS ester is a non-cleavable ADC linker containing the Maleimide group, 6-unit PEG, and NHS ester. | Inquiry | |
| BADC-00502 | ATFB-SE | 126695-58-7 |
| ATFB-SE is an ADC non-cleavable linker with breakthrough potential in the field of drug release carriers and targeted therapy. It can be used for biomolecule, protein and peptide labeling. | Inquiry | |
| BADC-00503 | N-Succinimidyl 4-(N-maleimidomethyl) trans-cyclohexane 1-carboxylate | 71875-81-5 |
| N-Succinimidyl 4-(N-maleimidomethyl) trans-cyclohexane 1-carboxylate is an essential compound in the biomedical sector that exhibits high complexity and variability in its applications. Acting as a reactive linker, it facilitates the conjugation of biomolecules to proteins, peptides, or drugs, thereby enabling targeted therapeutic delivery for addressing diverse ailments including cancer and autoimmune disorders. Embracing this compound empowers the biomedical industry to explore innovative means of combating diseases. | Inquiry | |
| BADC-00504 | 5-Maleimidovalericacid-NHS | 103750-03-4 |
| 5-Maleimidovalericacid-NHS is a widely used bioconjugation reagent in the biomedical field, which can modify molecules such as proteins and peptides by establishing long-lasting amide bonds. This facilitates the creation of targeted medication management and diagnostic tools. | Inquiry |
